A new $200M fund had identified healthcare as a key strategic area of interest, and they had an interest in identifying high potential investment opportunities that represented a right balance of large market opportunity and low overall business and technical risk. SI methodically reviewed over 300 early stage opportunities in medical device and biotech sectors, and conducted a thorough due diligence on the overall market opportunity, key technical, clinical and business risks, evaluation of the defensive and offensive strengths and weaknesses of the intellectual property, and a review of the regulatory strategy, reimbursement strategy, and competitive landscape for each proposed investment opportunity. All of the above analyses were integrated to provide a comprehensive evaluation of the key opportunities that represented the finalist target opportunities for our client’s investment portfolio.
We want to invest in healthcare, but what are the right investment opportunities to target to create a risk-balanced investment portfolio?
Previous
Previous